Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

FDA Backs PFAS In Medical Devices As Europe Moves To Ban Them And Suppliers Offer ...

7 September 2026 · By · Wire by Fusion42

Published

7 September 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at insights.citeline.com →

◆ Verified

Fusion42 · 7 September 2026 · Fusion42 review

The FDA has supported the use of PFAS chemicals in medical devices, while Europe is moving to ban PFAS in such applications, prompting suppliers to develop alternative materials. This regulatory divergence affects supply chains and compliance paths in medical device manufacturing.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You face different regulatory regimes for PFAS in medical devices between the US and Europe, making compliance and supply choices urgent for your manufacturing and market access strategies.

◆ Coverage

1 source · 7 Sep 2026

◆ Related on Wire

◆ Topics

Medtechpfasmedical-devicesregulatory-divergenceus-fdaeu-bancompliance